These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
¨
|
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
Maryland
|
|
27-0467113
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification Number)
|
|
Large accelerated filer
|
|
¨
|
|
Accelerated filer
|
|
x
|
|
|
|
|
|
|
|
|
|
Non-accelerated filer
|
|
¨
(Do not check if a smaller reporting company)
|
|
Smaller Reporting Company
|
|
¨
|
|
|
|
|
Page
|
|
|
|
|
|
|
|
|
March 31, 2014
|
|
December 31, 2013
|
||||
|
Assets:
|
|
|
|
||||
|
Cash
|
$
|
126,473
|
|
|
$
|
20,096
|
|
|
Restricted cash
|
30,127
|
|
|
30,127
|
|
||
|
Securities available-for-sale, at estimated fair value
|
25,477
|
|
|
33,362
|
|
||
|
Securities, at estimated fair value
|
151,134
|
|
|
158,086
|
|
||
|
Commercial mortgage loans, held for investment
|
185,516
|
|
|
161,099
|
|
||
|
Subordinate loans, held for investment
|
484,979
|
|
|
497,484
|
|
||
|
Interest receivable
|
6,220
|
|
|
6,022
|
|
||
|
Deferred financing costs, net
|
5,135
|
|
|
628
|
|
||
|
Other assets
|
550
|
|
|
600
|
|
||
|
Total Assets
|
$
|
1,015,611
|
|
|
$
|
907,504
|
|
|
Liabilities and Stockholders’ Equity
|
|
|
|
||||
|
Liabilities:
|
|
|
|
||||
|
Borrowings under repurchase agreements
|
$
|
166,994
|
|
|
$
|
202,033
|
|
|
Convertible senior notes, net
|
139,163
|
|
|
—
|
|
||
|
Accounts payable and accrued expenses
|
2,289
|
|
|
2,660
|
|
||
|
Payable to related party
|
2,565
|
|
|
2,628
|
|
||
|
Dividends payable
|
16,688
|
|
|
17,227
|
|
||
|
Total Liabilities
|
327,699
|
|
|
224,548
|
|
||
|
Commitments and Contingencies (see Note 14)
|
|
|
|
||||
|
Stockholders’ Equity:
|
|
|
|
||||
|
Preferred stock, $0.01 par value, 50,000,000 shares authorized and 3,450,000 shares issued and outstanding in 2014 and 2013
|
35
|
|
|
35
|
|
||
|
Common stock, $0.01 par value, 450,000,000 shares authorized, 37,125,475 and 36,888,467 shares issued and outstanding in 2014 and 2013, respectively
|
371
|
|
|
369
|
|
||
|
Additional paid-in-capital
|
701,797
|
|
|
697,610
|
|
||
|
Retained earnings (accumulated deficit)
|
(13,404
|
)
|
|
(14,188
|
)
|
||
|
Accumulated other comprehensive loss
|
(887
|
)
|
|
(870
|
)
|
||
|
Total Stockholders’ Equity
|
687,912
|
|
|
682,956
|
|
||
|
Total Liabilities and Stockholders’ Equity
|
$
|
1,015,611
|
|
|
$
|
907,504
|
|
|
|
Three months ended
March 31, |
||||||
|
|
2014
|
|
2013
|
||||
|
Net interest income:
|
|
|
|
||||
|
Interest income from securities
|
$
|
2,419
|
|
|
$
|
3,087
|
|
|
Interest income from commercial mortgage loans
|
4,011
|
|
|
3,592
|
|
||
|
Interest income from subordinate loans
|
14,730
|
|
|
11,454
|
|
||
|
Interest income from repurchase agreements
|
—
|
|
|
2
|
|
||
|
Interest expense
|
(1,757
|
)
|
|
(1,068
|
)
|
||
|
Net interest income
|
19,403
|
|
|
17,067
|
|
||
|
Operating expenses:
|
|
|
|
||||
|
General and administrative expenses (includes $426 and $883 of equity based compensation in 2014 and 2013, respectively)
|
(1,442
|
)
|
|
(1,895
|
)
|
||
|
Management fees to related party
|
(2,565
|
)
|
|
(2,160
|
)
|
||
|
Total operating expenses
|
(4,007
|
)
|
|
(4,055
|
)
|
||
|
Unrealized gain (loss) on securities
|
2,184
|
|
|
(1,080
|
)
|
||
|
Loss on derivative instruments (includes $72 of unrealized gains in 2013)
|
—
|
|
|
—
|
|
||
|
Net income
|
17,580
|
|
|
11,932
|
|
||
|
Preferred dividends
|
(1,860
|
)
|
|
(1,860
|
)
|
||
|
Net income available to common stockholders
|
$
|
15,720
|
|
|
$
|
10,072
|
|
|
Basic and diluted net income per share of common stock
|
$
|
0.42
|
|
|
$
|
0.33
|
|
|
Basic weighted average shares of common stock outstanding
|
37,122,842
|
|
|
30,105,939
|
|
||
|
Diluted weighted average shares of common stock outstanding
|
37,341,050
|
|
|
30,480,689
|
|
||
|
Dividend declared per share of common stock
|
$
|
0.40
|
|
|
$
|
0.40
|
|
|
|
Three months ended
March 31, |
||||||
|
|
2014
|
|
2013
|
||||
|
Net income available to common stockholders
|
$
|
15,720
|
|
|
$
|
10,072
|
|
|
Change in net unrealized gain (loss) on securities available-for-sale
|
(17
|
)
|
|
(158
|
)
|
||
|
Comprehensive income
|
$
|
15,703
|
|
|
$
|
9,914
|
|
|
|
Preferred Stock
|
|
Common Stock
|
|
Additional
Paid In
Capital
|
|
Retained
Earnings
(Accumulated
Deficit)
|
|
Accumulated
Other
Comprehensive
Income
|
|
|
||||||||||||||||||
|
|
Shares
|
|
Par
|
|
Shares
|
|
Par
|
|
|
|
|
Total
|
|||||||||||||||||
|
Balance at January 1, 2014
|
3,450,000
|
|
|
$
|
35
|
|
|
36,888,467
|
|
|
$
|
369
|
|
|
$
|
697,610
|
|
|
$
|
(14,188
|
)
|
|
$
|
(870
|
)
|
|
$
|
682,956
|
|
|
Capital decrease related to Equity Incentive Plan
|
—
|
|
|
—
|
|
|
237,008
|
|
|
2
|
|
|
(421
|
)
|
|
—
|
|
|
—
|
|
|
(419
|
)
|
||||||
|
Issuance of common stock
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Offering costs
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(9
|
)
|
|
—
|
|
|
—
|
|
|
(9
|
)
|
||||||
|
Convertible senior notes
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4,617
|
|
|
—
|
|
|
—
|
|
|
4,617
|
|
||||||
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
17,580
|
|
|
—
|
|
|
17,580
|
|
||||||
|
Change in net unrealized gain on securities available-for-sale
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(17
|
)
|
|
(17
|
)
|
||||||
|
Dividends on common stock
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(14,936
|
)
|
|
—
|
|
|
(14,936
|
)
|
||||||
|
Dividends on preferred stock
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,860
|
)
|
|
—
|
|
|
(1,860
|
)
|
||||||
|
Balance at March 31, 2014
|
3,450,000
|
|
|
$
|
35
|
|
|
37,125,475
|
|
|
$
|
371
|
|
|
$
|
701,797
|
|
|
$
|
(13,404
|
)
|
|
$
|
(887
|
)
|
|
$
|
687,912
|
|
|
|
Three months ended March 31, 2014
|
|
Three months ended March 31, 2013
|
||||
|
Cash flows provided by operating activities:
|
|
|
|
||||
|
Net income
|
$
|
17,580
|
|
|
$
|
11,932
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
||||
|
Premium amortization and (discount accretion), net
|
(256
|
)
|
|
(938
|
)
|
||
|
Amortization of deferred financing costs
|
190
|
|
|
193
|
|
||
|
Equity-based compensation
|
(421
|
)
|
|
883
|
|
||
|
Unrealized (gain) loss on securities
|
(2,184
|
)
|
|
1,080
|
|
||
|
Unrealized gain on derivative instruments
|
—
|
|
|
(72
|
)
|
||
|
Changes in operating assets and liabilities:
|
|
|
|
||||
|
Accrued interest receivable, less purchased interest
|
(3,125
|
)
|
|
(1,401
|
)
|
||
|
Other assets
|
50
|
|
|
203
|
|
||
|
Accounts payable and accrued expenses
|
(363
|
)
|
|
(85
|
)
|
||
|
Payable to related party
|
(63
|
)
|
|
123
|
|
||
|
Net cash provided by operating activities
|
11,408
|
|
|
11,918
|
|
||
|
Cash flows used in investing activities:
|
|
|
|
||||
|
Fees received from commercial mortgage loans
|
—
|
|
|
280
|
|
||
|
Funding of commercial mortgage loans
|
(24,178
|
)
|
|
—
|
|
||
|
Funding of subordinate loans
|
—
|
|
|
(91,297
|
)
|
||
|
Principal payments received on securities available-for-sale
|
7,785
|
|
|
2,544
|
|
||
|
Principal payments received on securities at estimated fair value
|
9,080
|
|
|
12,429
|
|
||
|
Principal payments received on commercial mortgage loans
|
243
|
|
|
623
|
|
||
|
Principal payments received on subordinate loans
|
15,407
|
|
|
52,305
|
|
||
|
Principal payments received on repurchase agreements
|
—
|
|
|
6,598
|
|
||
|
Net cash provided by (used in) investing activities
|
8,337
|
|
|
(16,518
|
)
|
||
|
Cash flows from financing activities:
|
|
|
|
||||
|
Proceeds from issuance of common stock
|
—
|
|
|
148,804
|
|
||
|
Payment of offering costs
|
(117
|
)
|
|
(308
|
)
|
||
|
Proceeds from repurchase agreement borrowings
|
12,000
|
|
|
—
|
|
||
|
Repayments of repurchase agreement borrowings
|
(47,039
|
)
|
|
(13,214
|
)
|
||
|
Proceeds from issuance of convertible senior notes
|
143,750
|
|
|
—
|
|
||
|
Payment of deferred financing costs
|
(4,627
|
)
|
|
(500
|
)
|
||
|
Dividends on common stock
|
(15,475
|
)
|
|
(11,218
|
)
|
||
|
Dividends on preferred stock
|
(1,860
|
)
|
|
(1,860
|
)
|
||
|
Net cash provided by (used in) financing activities
|
86,632
|
|
|
121,704
|
|
||
|
Net increase (decrease) in cash and cash equivalents
|
106,377
|
|
|
117,104
|
|
||
|
Cash and cash equivalents, beginning of period
|
20,096
|
|
|
108,619
|
|
||
|
Cash and cash equivalents, end of period
|
$
|
126,473
|
|
|
$
|
225,723
|
|
|
Supplemental disclosure of cash flow information:
|
|
|
|
||||
|
Interest paid
|
$
|
1,958
|
|
|
$
|
916
|
|
|
Supplemental disclosure of non-cash financing activities:
|
|
|
|
||||
|
Dividend declared, not yet paid
|
$
|
16,688
|
|
|
$
|
16,616
|
|
|
Deferred financing costs, not yet paid
|
$
|
412
|
|
|
$
|
254
|
|
|
Offering costs payable
|
$
|
—
|
|
|
$
|
395
|
|
|
|
Fair Value as of March 31, 2014
|
|
Fair Value as of December 31, 2013
|
||||||||||||||||||||||||||||
|
|
Level I
|
|
Level II
|
|
Level III
|
|
Total
|
|
Level I
|
|
Level II
|
|
Level III
|
|
Total
|
||||||||||||||||
|
CMBS (Available-for-Sale)
|
$
|
—
|
|
|
$
|
25,477
|
|
|
$
|
—
|
|
|
$
|
25,477
|
|
|
$
|
—
|
|
|
$
|
33,362
|
|
|
$
|
—
|
|
|
$
|
33,362
|
|
|
CMBS (Fair Value Option)
|
—
|
|
|
151,134
|
|
|
—
|
|
|
151,134
|
|
|
—
|
|
|
158,086
|
|
|
—
|
|
|
158,086
|
|
||||||||
|
Total
|
$
|
—
|
|
|
$
|
176,611
|
|
|
$
|
—
|
|
|
$
|
176,611
|
|
|
$
|
—
|
|
|
$
|
191,448
|
|
|
$
|
—
|
|
|
$
|
191,448
|
|
|
Security Description
|
Face
Amount
|
|
Amortized
Cost
|
|
Gross
Unrealized
Gain
|
|
Gross
Unrealized
Loss
|
|
Estimated
Fair
Value
|
||||||||||
|
CMBS (Available-for-Sale)
|
$
|
25,281
|
|
|
$
|
26,364
|
|
|
$
|
—
|
|
|
$
|
(887
|
)
|
|
$
|
25,477
|
|
|
CMBS (Fair Value Option)
|
146,497
|
|
|
146,810
|
|
|
4,432
|
|
|
(108
|
)
|
|
151,134
|
|
|||||
|
Total
|
$
|
171,778
|
|
|
$
|
173,174
|
|
|
$
|
4,432
|
|
|
$
|
(995
|
)
|
|
$
|
176,611
|
|
|
Security Description
|
Face
Amount
|
|
Amortized
Cost
|
|
Gross
Unrealized
Gain
|
|
Gross
Unrealized
Loss
|
|
Estimated
Fair
Value
|
||||||||||
|
CMBS (Available-for-Sale)
|
$
|
33,066
|
|
|
$
|
34,232
|
|
|
$
|
—
|
|
|
$
|
(870
|
)
|
|
$
|
33,362
|
|
|
CMBS (Fair Value Option)
|
155,577
|
|
|
155,946
|
|
|
2,313
|
|
|
(173
|
)
|
|
158,086
|
|
|||||
|
Total
|
$
|
188,643
|
|
|
$
|
190,178
|
|
|
$
|
2,313
|
|
|
$
|
(1,043
|
)
|
|
$
|
191,448
|
|
|
|
March 31, 2014
|
|
December 31, 2013
|
||
|
Credit Ratings *
|
AAA-CCC
|
|
|
AAA-CCC
|
|
|
Coupon
|
5.8
|
%
|
|
5.8
|
%
|
|
Yield
|
5.4
|
%
|
|
5.3
|
%
|
|
Weighted Average Life
|
3.1 years
|
|
|
3.1 years
|
|
|
*
|
Ratings per Fitch Ratings, Moody’s Investors Service or Standard & Poor's.
|
|
Vintage
|
March 31, 2014
|
|
December 31, 2013
|
||
|
2006
|
3
|
%
|
|
3
|
%
|
|
2007
|
97
|
|
|
97
|
|
|
Total
|
100
|
%
|
|
100
|
%
|
|
Property Type
|
March 31, 2014
|
|
December 31, 2013
|
||
|
Office
|
36.0
|
%
|
|
35.5
|
%
|
|
Retail
|
24.0
|
|
|
24.1
|
|
|
Hotel
|
13.8
|
|
|
13.7
|
|
|
Multifamily
|
12.1
|
|
|
12.7
|
|
|
Other *
|
14.1
|
|
|
14.0
|
|
|
Total
|
100
|
%
|
|
100
|
%
|
|
Location
|
March 31, 2014
|
|
December 31, 2013
|
||
|
South Atlantic
|
23.8
|
%
|
|
23.4
|
%
|
|
Middle Atlantic
|
23.0
|
|
|
22.8
|
|
|
Pacific
|
17.0
|
|
|
17.6
|
|
|
East North Central
|
10.3
|
|
|
—
|
|
|
Other *
|
25.9
|
|
|
36.2
|
|
|
Total
|
100
|
%
|
|
100
|
%
|
|
Description
|
Date of
Investment
|
|
Maturity
Date
|
|
Original
Face
Amount
|
|
Current
Face
Amount
|
|
Carrying
Value
|
|
Coupon
|
|
Property Size
|
|||||||
|
Hotel - NY, NY
|
Jan-10
|
|
Feb-15
|
|
$
|
32,000
|
|
|
$
|
31,242
|
|
|
$
|
31,242
|
|
|
Fixed
|
|
|
151 rooms
|
|
Office Condo (Headquarters) - NY, NY
|
Feb-10
|
|
Feb-15
|
|
28,000
|
|
|
27,095
|
|
|
27,095
|
|
|
Fixed
|
|
|
73,419 sq. ft.
|
|||
|
Hotel - Silver Spring, MD
|
Mar-10
|
|
Apr-15
|
|
26,000
|
|
|
24,853
|
|
|
24,722
|
|
|
Fixed
|
|
|
263 rooms
|
|||
|
Condo Conversion – NY, NY (1)
|
Dec-12
|
|
Jan-15
|
|
45,000
|
|
|
45,000
|
|
|
45,002
|
|
|
Floating
|
|
|
119,000 sq. ft.
|
|||
|
Condo Conversion – NY, NY (2)
|
Aug-13
|
|
Sept-15
|
|
33,000
|
|
|
33,333
|
|
|
33,220
|
|
|
Floating
|
|
|
40,000 sq. ft.
|
|||
|
Condo Construction - Potomac, MD (3)
|
Feb-14
|
|
Sept-16
|
|
25,000
|
|
|
25,000
|
|
|
24,235
|
|
|
Floating
|
|
|
50 units
|
|||
|
Total/Weighted Average
|
|
|
|
|
$
|
189,000
|
|
|
$
|
186,523
|
|
|
$
|
185,516
|
|
|
8.83
|
%
|
|
|
|
(1)
|
This loan includes
two
one
-year extension options subject to certain conditions and the payment of a fee for each extension.
|
|
(2)
|
This loan includes a
one
-year extension option subject to certain conditions and the payment of a fee.
|
|
(3)
|
This loan includes a six month extension option subject to certain conditions and the payment of a fee.
|
|
Description
|
Date of
Investment
|
|
Maturity
Date
|
|
Original
Face
Amount
|
|
Current
Face
Amount
|
|
Carrying
Value
|
|
Coupon
|
|
Property Size
|
|||||||
|
Hotel - NY, NY
|
Jan-10
|
|
Feb-15
|
|
$
|
32,000
|
|
|
$
|
31,317
|
|
|
$
|
31,317
|
|
|
Fixed
|
|
|
151 rooms
|
|
Office Condo (Headquarters) - NY, NY
|
Feb-10
|
|
Feb-15
|
|
28,000
|
|
|
27,169
|
|
|
27,169
|
|
|
Fixed
|
|
|
73,419 sq. ft.
|
|||
|
Hotel - Silver Spring, MD
|
Mar-10
|
|
Apr-15
|
|
26,000
|
|
|
24,947
|
|
|
24,785
|
|
|
Fixed
|
|
|
263 rooms
|
|||
|
Condo Conversion – NY, NY (1)
|
Dec-12
|
|
Jan-15
|
|
45,000
|
|
|
45,000
|
|
|
44,867
|
|
|
Floating
|
|
|
119,000 sq. ft.
|
|||
|
Condo Conversion – NY, NY (2)
|
Aug-13
|
|
Sept-15
|
|
33,000
|
|
|
33,167
|
|
|
32,961
|
|
|
Floating
|
|
|
40,000 sq. ft.
|
|||
|
Total/Weighted Average
|
|
|
|
|
$
|
164,000
|
|
|
$
|
161,600
|
|
|
$
|
161,099
|
|
|
8.82
|
%
|
|
|
|
(1)
|
This loan includes
two
one
-year extension options subject to certain conditions and the payment of a fee for each extension.
|
|
(2)
|
This loan includes a
one
-year extension option subject to certain conditions and the payment of a fee.
|
|
Description
|
Date of
Investment
|
|
Maturity
Date
|
|
Original
Face
Amount
|
|
Current
Face
Amount
|
|
Carrying
Value
|
|
Coupon
|
|||||||
|
Office - Michigan
|
May-10
|
|
Jun-20
|
|
$
|
9,000
|
|
|
$
|
8,849
|
|
|
$
|
8,849
|
|
|
Fixed
|
|
|
Ski Resort - California
|
Apr-11
|
|
May-17
|
|
40,000
|
|
|
40,000
|
|
|
39,632
|
|
|
Fixed
|
|
|||
|
Mixed Use – North Carolina
|
Jul-12
|
|
Jul-22
|
|
6,525
|
|
|
6,525
|
|
|
6,525
|
|
|
Fixed
|
|
|||
|
Office Complex - Missouri
|
Sept-12
|
|
Oct-22
|
|
10,000
|
|
|
9,814
|
|
|
9,814
|
|
|
Fixed
|
|
|||
|
Hotel Portfolio – Various (1)
|
Nov-12
|
|
Nov-15
|
|
50,000
|
|
|
48,271
|
|
|
48,277
|
|
|
Floating
|
|
|||
|
Condo Conversion – NY, NY (2)
|
Dec-12
|
|
Jan-15
|
|
35,000
|
|
|
35,000
|
|
|
34,878
|
|
|
Floating
|
|
|||
|
Condo Construction – NY, NY (1)
|
Jan-13
|
|
Jul-17
|
|
60,000
|
|
|
69,035
|
|
|
68,565
|
|
|
Fixed
|
|
|||
|
Multifamily Conversion – NY, NY (1)
|
Jan-13
|
|
Dec-14
|
|
18,000
|
|
|
18,000
|
|
|
17,932
|
|
|
Floating
|
|
|||
|
Hotel Portfolio – Rochester, MN
|
Jan-13
|
|
Feb-18
|
|
25,000
|
|
|
24,696
|
|
|
24,696
|
|
|
Fixed
|
|
|||
|
Warehouse Portfolio - Various
|
May-13
|
|
May-23
|
|
32,000
|
|
|
32,000
|
|
|
32,000
|
|
|
Fixed
|
|
|||
|
Multifamily Conversion – NY, NY (3)
|
May-13
|
|
Jun-14
|
|
44,000
|
|
|
44,000
|
|
|
43,937
|
|
|
Floating
|
|
|||
|
Office Condo - NY, NY
|
Jul-13
|
|
Jul-22
|
|
14,000
|
|
|
14,000
|
|
|
13,572
|
|
|
Fixed
|
|
|||
|
Condo Conversion – NY, NY (4)
|
Aug-13
|
|
Sept-15
|
|
294
|
|
|
297
|
|
|
1
|
|
|
Floating
|
|
|||
|
Mixed Use - Pittsburgh, PA (1)
|
Aug-13
|
|
Aug-16
|
|
22,500
|
|
|
22,500
|
|
|
22,378
|
|
|
Floating
|
|
|||
|
Healthcare Portfolio - Various
|
Oct-13
|
|
Jun-14
|
|
47,000
|
|
|
47,000
|
|
|
47,000
|
|
|
Floating
|
|
|||
|
Mixed Use - Florida (2)
|
Nov-13
|
|
Oct-18
|
|
50,000
|
|
|
50,000
|
|
|
49,611
|
|
|
Floating
|
|
|||
|
Mixed Use - Various (2)
|
Dec-13
|
|
Dec-18
|
|
17,000
|
|
|
17,500
|
|
|
17,312
|
|
|
Fixed
|
|
|||
|
Total/Weighted Average
|
|
|
|
|
$
|
480,319
|
|
|
$
|
487,487
|
|
|
$
|
484,979
|
|
|
11.60
|
%
|
|
(1)
|
Includes a
one
-year extension option subject to certain conditions and the payment of an extension fee.
|
|
(2)
|
Includes
two
one
-year extension options subject to certain conditions and the payment of a fee for each extension.
|
|
(3)
|
Includes a
three
-month extension option subject to certain conditions and the payment of an extension fee.
|
|
(4)
|
Includes a
one
-year extension option subject to certain conditions and the payment of an extension fee. As of
March 31, 2014
, the Company had
$29,106
of unfunded loan commitments related to this loan.
|
|
Description
|
Date of
Investment |
|
Maturity
Date |
|
Original
Face Amount |
|
Current
Face Amount |
|
Carrying
Value |
|
Coupon
|
|||||||
|
Office - Michigan
|
May-10
|
|
Jun-20
|
|
$
|
9,000
|
|
|
$
|
8,866
|
|
|
$
|
8,866
|
|
|
Fixed
|
|
|
Ski Resort - California
|
Apr-11
|
|
May-17
|
|
40,000
|
|
|
40,000
|
|
|
39,781
|
|
|
Fixed
|
|
|||
|
Hotel– New York (1)
|
Jan-12
|
|
Feb-14
|
|
15,000
|
|
|
15,000
|
|
|
15,207
|
|
|
Fixed
|
|
|||
|
Mixed Use – North Carolina
|
Jul-12
|
|
Jul-22
|
|
6,525
|
|
|
6,525
|
|
|
6,525
|
|
|
Fixed
|
|
|||
|
Office Complex - Missouri
|
Sept-12
|
|
Oct-22
|
|
10,000
|
|
|
9,849
|
|
|
9,849
|
|
|
Fixed
|
|
|||
|
Hotel Portfolio – Various (1)
|
Nov-12
|
|
Nov-15
|
|
50,000
|
|
|
48,431
|
|
|
48,397
|
|
|
Floating
|
|
|||
|
Condo Conversion – NY, NY (2)
|
Dec-12
|
|
Jan-15
|
|
35,000
|
|
|
35,000
|
|
|
34,734
|
|
|
Floating
|
|
|||
|
Condo Construction – NY, NY (1)
|
Jan-13
|
|
Jul-17
|
|
60,000
|
|
|
66,800
|
|
|
66,340
|
|
|
Fixed
|
|
|||
|
Multifamily Conversion – NY, NY (1)
|
Jan-13
|
|
Dec-14
|
|
18,000
|
|
|
18,000
|
|
|
17,906
|
|
|
Floating
|
|
|||
|
Hotel Portfolio – Rochester, MN
|
Jan-13
|
|
Feb-18
|
|
25,000
|
|
|
24,771
|
|
|
24,771
|
|
|
Fixed
|
|
|||
|
Warehouse Portfolio - Various
|
May-13
|
|
May-23
|
|
32,000
|
|
|
32,000
|
|
|
32,000
|
|
|
Fixed
|
|
|||
|
Multifamily Conversion – NY, NY (3)
|
May-13
|
|
Jun-14
|
|
44,000
|
|
|
44,000
|
|
|
43,859
|
|
|
Floating
|
|
|||
|
Office Condo - NY, NY
|
Jul-13
|
|
Jul-22
|
|
14,000
|
|
|
14,000
|
|
|
13,565
|
|
|
Fixed
|
|
|||
|
Condo Conversion – NY, NY (4)
|
Aug-13
|
|
Sept-15
|
|
294
|
|
|
295
|
|
|
2
|
|
|
Floating
|
|
|||
|
Mixed Use - Pittsburgh, PA (1)
|
Aug-13
|
|
Aug-16
|
|
22,500
|
|
|
22,500
|
|
|
22,342
|
|
|
Floating
|
|
|||
|
Healthcare Portfolio - Various
|
Oct-13
|
|
Jun-14
|
|
47,000
|
|
|
47,000
|
|
|
47,000
|
|
|
Floating
|
|
|||
|
Mixed Use - Florida (2)
|
Nov-13
|
|
Oct-18
|
|
50,000
|
|
|
50,000
|
|
|
49,535
|
|
|
Floating
|
|
|||
|
Mixed Use - Various (2)
|
Dec-13
|
|
Dec-18
|
|
17,000
|
|
|
17,000
|
|
|
16,805
|
|
|
Fixed
|
|
|||
|
Total/Weighted Average
|
|
|
|
|
$
|
495,319
|
|
|
$
|
500,037
|
|
|
$
|
497,484
|
|
|
11.60
|
%
|
|
(1)
|
Includes a
one
-year extension option subject to certain conditions and the payment of an extension fee.
|
|
(2)
|
Includes
two
one
-year extension options subject to certain conditions and the payment of a fee for each extension.
|
|
(3)
|
Includes a
three
-month extension option subject to certain conditions and the payment of an extension fee.
|
|
(4)
|
Includes a
one
-year extension option subject to certain conditions and the payment of an extension fee. As of
December 31, 2013
, the Company had
$29,106
of unfunded loan commitments related to this loan.
|
|
|
March 31, 2014
|
|
December 31, 2013
|
|
|
||||||||||||||
|
|
Debt
Balance
|
|
Weighted
Average
Remaining
Maturity
|
|
Weighted
Average
Rate
|
|
Debt
Balance
|
|
Weighted
Average
Remaining
Maturity
|
|
Weighted
Average
Rate
|
|
|
||||||
|
Wells Facility borrowings
|
$
|
33,092
|
|
|
0.9 years
|
|
1.0
|
%
|
|
$
|
47,751
|
|
|
0.2 years
|
*
|
1.2
|
%
|
|
**
|
|
UBS Facility borrowings
|
133,899
|
|
|
4.5 years
|
*
|
2.8
|
%
|
|
133,899
|
|
|
4.7 years
|
|
2.8
|
%
|
|
Fixed
|
||
|
JPMorgan Facility borrowings
|
3
|
|
|
0.8 years
|
|
2.7
|
%
|
|
20,383
|
|
|
1.1 years
|
|
2.7
|
%
|
|
L+250
|
||
|
Total borrowings
|
$
|
166,994
|
|
|
3.8 years
|
|
2.4
|
%
|
|
$
|
202,033
|
|
|
3.3 years
|
|
2.4
|
%
|
|
|
|
|
Less than
1 year
|
|
1 to 3
years
|
|
3 to 5
years
|
|
More than
5 years
|
|
Total
|
||||||||||
|
Wells Facility borrowings
|
$
|
33,092
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
33,092
|
|
|
UBS Facility borrowings *
|
—
|
|
|
5,004
|
|
|
128,895
|
|
|
—
|
|
|
133,899
|
|
|||||
|
JPMorgan Facility borrowings
|
3
|
|
|
|
|
|
—
|
|
|
—
|
|
|
3
|
|
|||||
|
Total
|
$
|
33,095
|
|
|
$
|
5,004
|
|
|
$
|
128,895
|
|
|
$
|
—
|
|
|
$
|
166,994
|
|
|
|
|
|
For the three months ended March 31, 2014
|
||||||||
|
|
Balance at March 31, 2014
|
|
Maximum Month-End
Balance
|
|
Average Month-End
Balance
|
||||||
|
Wells Facility borrowings
|
$
|
33,092
|
|
|
$
|
47,751
|
|
|
$
|
38,564
|
|
|
UBS Facility borrowings
|
133,899
|
|
|
133,899
|
|
|
133,899
|
|
|||
|
JPMorgan Facility borrowings
|
3
|
|
|
32,383
|
|
|
21,277
|
|
|||
|
Total
|
$
|
166,994
|
|
|
|
|
|
||||
|
|
Principal Amount
|
Coupon Rate
|
Effective Rate (1)
|
Conversion Rate (2)
|
Maturity Date
|
Remaining Period of Amortization
|
|||||
|
2019 Notes
|
$
|
143,750
|
|
5.50
|
%
|
6.25
|
%
|
55.3649
|
|
3/15/2019
|
4.76 years
|
|
(1)
|
Effective rate includes the effect of the adjustment for the conversion option, the value of which reduced the initial liability and was recorded in additional paid-in-capital.
|
|
(2)
|
The Company has the option to settle any conversions in cash, shares of common stock or a combination thereof. The conversion rate represents the number of shares of common stock issuable per $1,000 principal amount of 2019 Notes converted. The if-converted value of the 2019 Notes does not exceed their principal amount at
March 31, 2014
since the closing market price of the Company’s common stock of
$16.63
per share does not exceed the implicit conversion prices of
$18.06
for the 2019 Notes .
|
|
|
|
Three months ended March 31,
|
||||||
|
|
Location of Loss Recognized in Income
|
2014
|
|
2013
|
||||
|
Interest rate swaps
|
Loss on derivative instruments – realized *
|
$
|
—
|
|
|
$
|
(72
|
)
|
|
Interest rate swaps
|
Gain on derivative instruments – unrealized
|
—
|
|
|
72
|
|
||
|
Interest rate caps
|
Loss on derivative instruments - unrealized
|
—
|
|
|
—
|
|
||
|
Total
|
|
$
|
—
|
|
|
$
|
—
|
|
|
*
|
Realized losses represent net amounts accrued for the Company’s derivative instruments during the period.
|
|
|
Type
|
Date
|
|
Restricted Stock
|
|
RSUs
|
|
Estimate Fair Value
on Grant Date |
|
Initial Vesting
|
|
Final Vesting
|
||
|
Outstanding at December 31, 2013
|
|
208,416
|
|
|
503,750
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
Canceled upon delivery
|
January 2014
|
|
—
|
|
|
(288,750
|
)
|
|
n/a
|
|
n/a
|
|
n/a
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Outstanding at March 31, 2014
|
|
208,416
|
|
|
215,000
|
|
|
|
|
|
|
|
||
|
Vesting Date
|
Shares Vesting
|
|
RSU Vesting
|
|
Total Awards
|
|||
|
April 2014
|
2,925
|
|
|
417
|
|
|
3,342
|
|
|
July 2014
|
2,157
|
|
|
—
|
|
|
2,157
|
|
|
July 2014
|
500
|
|
|
—
|
|
|
500
|
|
|
October 2014
|
2,153
|
|
|
—
|
|
|
2,153
|
|
|
December 2014
|
6,668
|
|
|
63,332
|
|
|
70,000
|
|
|
January 2015
|
2,160
|
|
|
—
|
|
|
2,160
|
|
|
March 2015
|
—
|
|
|
6,667
|
|
|
6,667
|
|
|
April 2015
|
2,161
|
|
|
—
|
|
|
2,161
|
|
|
July 2015
|
1,361
|
|
|
—
|
|
|
1,361
|
|
|
July 2015
|
500
|
|
|
—
|
|
|
500
|
|
|
October 2015
|
1,361
|
|
|
—
|
|
|
1,361
|
|
|
December 2015
|
6,668
|
|
|
63,341
|
|
|
70,009
|
|
|
January 2016
|
1,360
|
|
|
—
|
|
|
1,360
|
|
|
April 2016
|
1,361
|
|
|
—
|
|
|
1,361
|
|
|
July 2016
|
417
|
|
|
—
|
|
|
417
|
|
|
October 2016
|
416
|
|
|
—
|
|
|
416
|
|
|
|
32,168
|
|
|
133,757
|
|
|
165,925
|
|
|
Declaration Date
|
Record Date
|
Payment Date
|
Amount
|
||
|
February 26, 2014
|
March 31, 2014
|
April 15, 2014
|
$
|
0.40
|
|
|
Declaration Date
|
Record Date
|
Payment Date
|
Amount
|
||
|
March 17, 2014
|
March 31, 2014
|
April 15, 2014
|
$
|
0.5391
|
|
|
|
March 31, 2014
|
|
December 31, 2013
|
||||||||||||
|
|
Carrying
Value
|
|
Estimated
Fair Value
|
|
Carrying
Value
|
|
Estimated
Fair Value
|
||||||||
|
Cash and cash equivalents
|
$
|
126,473
|
|
|
$
|
126,473
|
|
|
$
|
20,096
|
|
|
$
|
20,096
|
|
|
Restricted cash
|
30,127
|
|
|
30,127
|
|
|
30,127
|
|
|
30,127
|
|
||||
|
Commercial first mortgage loans
|
185,516
|
|
|
188,708
|
|
|
161,099
|
|
|
164,405
|
|
||||
|
Subordinate loans
|
484,979
|
|
|
490,564
|
|
|
497,484
|
|
|
503,267
|
|
||||
|
Borrowings under repurchase agreements
|
(166,994
|
)
|
|
(165,223
|
)
|
|
(202,033
|
)
|
|
(202,148
|
)
|
||||
|
Convertible senior notes, net
|
(139,163
|
)
|
|
(146,050
|
)
|
|
—
|
|
|
—
|
|
||||
|
|
For the three
months ended March 31, |
||||||
|
|
2014
|
|
2013
|
||||
|
Numerator:
|
|
|
|
||||
|
Net income
|
$
|
17,580
|
|
|
$
|
11,932
|
|
|
Preferred dividends
|
(1,860
|
)
|
|
(1,860
|
)
|
||
|
Net income available to common stockholders
|
15,720
|
|
|
10,072
|
|
||
|
Dividends declared on common stock
|
(14,850
|
)
|
|
(14,748
|
)
|
||
|
Dividends on participating securities
|
(86
|
)
|
|
(195
|
)
|
||
|
Net income (loss) attributable to common stockholders
|
$
|
784
|
|
|
$
|
(4,871
|
)
|
|
Denominator:
|
|
|
|
||||
|
Basic weighted average shares of common stock outstanding
|
37,122,842
|
|
|
30,105,939
|
|
||
|
Diluted weighted average shares of common stock outstanding
|
37,341,050
|
|
|
30,480,689
|
|
||
|
Basic and diluted net income (loss) per weighted average share of common stock
|
|
|
|
||||
|
Distributable Earnings
|
$
|
0.40
|
|
|
$
|
0.49
|
|
|
Undistributed income (loss)
|
$
|
0.02
|
|
|
$
|
(0.16
|
)
|
|
Basic and diluted net income per share of common stock
|
$
|
0.42
|
|
|
$
|
0.33
|
|
|
Description
|
Face
Amount |
|
Amortized
Cost |
|
Weighted
Average Yield |
|
Remaining
Weighted Average Life (years) |
|
Debt
|
|
Cost of
Funds |
|
Remaining
Debt Term (years) (1) |
|
Equity at
cost (2) |
|
Current
Weighted Average Underwritten IRR (3) |
|
Levered
Weighted Average Underwritten IRR (4) |
||||||||||||||
|
First mortgages
|
$
|
186,523
|
|
|
$
|
185,516
|
|
|
10.1
|
%
|
|
1.9
|
|
|
$
|
3
|
|
|
2.7
|
%
|
|
0.8
|
|
|
$
|
185,513
|
|
|
11.1
|
%
|
|
18.8
|
%
|
|
Subordinate loans
|
487,487
|
|
|
484,979
|
|
|
12.4
|
|
|
3.7
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
484,979
|
|
|
13.1
|
|
|
13.1
|
|
||||
|
CMBS
|
171,778
|
|
|
173,174
|
|
|
5.4
|
|
|
3.1
|
|
|
166,991
|
|
|
2.4
|
|
|
3.8
|
|
|
36,310
|
|
|
13.9
|
|
|
13.9
|
|
||||
|
Total/Weighted Average
|
$
|
845,788
|
|
|
$
|
843,669
|
|
|
10.4
|
%
|
|
3.2
|
|
|
$
|
166,994
|
|
|
2.4
|
%
|
|
3.8
|
|
|
$
|
706,802
|
|
|
12.6
|
%
|
|
14.1
|
%
|
|
(1)
|
Assumes extension options are exercised. See “—Liquidity and Capital Resources - Borrowings Under Various Financing Arrangements” below for a discussion of the Company's repurchase agreements.
|
|
(2)
|
Includes
$30,127
of restricted cash related to the UBS Facility.
|
|
(3)
|
The IRR for the investments shown in the above table reflect the returns underwritten by the Manager, calculated on a weighted average basis assuming no dispositions, early prepayments or defaults but assuming that extension options are exercised and that the cost of borrowings under the Wells Facility remains constant over the remaining terms and extension terms under this facility. With respect to certain loans, the IRR calculation assumes certain estimates with respect to the timing and magnitude of future fundings for the remaining commitments and associated loan repayments, and assumes no defaults. IRR is the annualized effective compounded return rate that accounts for the time-value of money and represents the rate of return on an investment over a holding period expressed as a percentage of the investment. It is the discount rate that makes the net present value of all cash outflows (the costs of investment) equal to the net present value of cash inflows (returns on investment). It is derived from the negative and positive cash flows resulting from or produced by each transaction (or for a transaction involving more than one investment, cash flows resulting from or produced by each of the investments), whether positive, such as investment returns, or negative, such as transaction expenses or other costs of investment, taking into account the dates on which such cash flows occurred or are expected to occur, and compounding interest accordingly. There can be no assurance that the actual IRRs will equal the underwritten IRRs shown in the table. See “Item 1A—Risk Factors—The Company may not achieve its underwritten internal rate of return on its investments which may lead to future returns that may be significantly lower than anticipated” included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013 for a discussion of some of the factors that could adversely impact the returns received by the Company from the investments shown in the table or elsewhere in this quarterly report over time.
|
|
(4)
|
Substantially all of the Company’s borrowings under the JPMorgan Facility have been repaid as of
March 31, 2014
. The Company’s ability to achieve its underwritten levered weighted average IRR with regard to its portfolio of first mortgage loans is additionally dependent upon the Company reborrowing approximately $88,000 under the JPMorgan Facility or any replacement facility. Without such reborrowing, the levered weighted average underwritten IRRs will be as indicated in the current weighted average underwritten IRR column above.
|
|
|
Three months ended March 31,
|
|||||||||||||
|
|
2014
|
|
2013
|
|
Change
(amount) |
|
Change
(%) |
|||||||
|
Interest income from:
|
|
|
|
|
|
|
|
|||||||
|
Securities
|
$
|
2,419
|
|
|
$
|
3,087
|
|
|
$
|
(668
|
)
|
|
(21.6
|
)%
|
|
Commercial mortgage loans
|
4,011
|
|
|
3,592
|
|
|
419
|
|
|
11.7
|
%
|
|||
|
Subordinate loans
|
14,730
|
|
|
11,454
|
|
|
3,276
|
|
|
28.6
|
%
|
|||
|
Repurchase agreements
|
—
|
|
|
2
|
|
|
(2
|
)
|
|
(100.0
|
)%
|
|||
|
Interest expense
|
(1,757
|
)
|
|
(1,068
|
)
|
|
(689
|
)
|
|
64.5
|
%
|
|||
|
Net interest income
|
$
|
19,403
|
|
|
$
|
17,067
|
|
|
$
|
2,336
|
|
|
13.7
|
%
|
|
|
Three months ended March 31,
|
|||||||||||||
|
|
2014
|
|
2013
|
|
Change
(amount) |
|
Change
(%) |
|||||||
|
General and administrative expense
|
$
|
1,016
|
|
|
$
|
1,012
|
|
|
$
|
4
|
|
|
0.4
|
%
|
|
Stock-based compensation expense
|
426
|
|
|
883
|
|
|
(457
|
)
|
|
(51.8
|
)%
|
|||
|
Management fee expense
|
2,565
|
|
|
2,160
|
|
|
405
|
|
|
18.8
|
%
|
|||
|
Total operating expense
|
$
|
4,007
|
|
|
$
|
4,055
|
|
|
$
|
(48
|
)
|
|
(1.2
|
)%
|
|
|
|
Three months ended March 31,
|
||||||
|
|
Location of Gain (Loss) Recognized in Income
|
2014
|
|
2013
|
||||
|
Securities
|
Unrealized gain (loss) on securities
|
2,184
|
|
|
(1,080
|
)
|
||
|
Interest rate swaps
|
Loss on derivative instruments – realized *
|
—
|
|
|
(72
|
)
|
||
|
Interest rate swaps
|
Gain on derivative instruments – unrealized
|
—
|
|
|
72
|
|
||
|
Total
|
|
$
|
2,184
|
|
|
$
|
(1,080
|
)
|
|
*
|
Realized losses represent net amounts expensed related to the exchange of fixed and floating rate cash flows for the Company’s derivative instruments during the period.
|
|
Declaration Date
|
Record Date
|
Payment Date
|
Amount
|
||
|
February 26, 2014
|
March 31, 2014
|
April 15, 2014
|
$
|
0.40
|
|
|
Declaration Date
|
Record Date
|
Payment Date
|
Amount
|
||
|
March 17, 2014
|
March 31, 2014
|
April 15, 2014
|
$
|
0.5391
|
|
|
•
|
no investment will be made that would cause the Company to fail to qualify as a REIT for U.S. federal income tax purposes;
|
|
•
|
no investment will be made that would cause the Company to register as an investment company under the 1940 Act;
|
|
•
|
investments will be predominantly in the Company’s target assets;
|
|
•
|
no more than 20% of the Company’s cash equity (on a consolidated basis) will be invested in any single investment at the time of the investment;
|
|
•
|
until appropriate investments can be identified, the Manager may invest the proceeds of any offering in interest bearing, short-term investments, including money market accounts and/or funds, that are consistent with the Company’s intention to qualify as a REIT.
|
|
|
Less than 1
year |
|
1 to 3
years |
|
3 to 5
years |
|
More than
5 years |
|
Total
|
||||||||||
|
Wells Facility borrowings *
|
$
|
33,344
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
33,344
|
|
|
UBS Facility borrowings **
|
4,740
|
|
|
62,409
|
|
|
79,503
|
|
|
—
|
|
|
146,652
|
|
|||||
|
JPMorgan Facility borrowings*
|
3
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3
|
|
|||||
|
Total
|
$
|
38,087
|
|
|
$
|
62,409
|
|
|
$
|
79,503
|
|
|
$
|
—
|
|
|
$
|
179,999
|
|
|
*
|
Assumes current LIBOR of 0.16% for interest payments due under the JPMorgan Facility and Wells Facility.
|
|
|
For the three months ended
March 31, |
||||||
|
|
2014
|
|
2013
|
||||
|
Net income available to common stockholders
|
$
|
15,720
|
|
|
$
|
10,072
|
|
|
Adjustments:
|
|
|
|
||||
|
Unrealized (gain) loss on securities
|
(2,184
|
)
|
|
1,080
|
|
||
|
Unrealized (gain) loss on derivative instruments
|
—
|
|
|
(72
|
)
|
||
|
Equity-based compensation expense
|
426
|
|
|
883
|
|
||
|
Amortization of the 2019 Notes related to equity reclassification
|
29
|
|
|
—
|
|
||
|
Total adjustments:
|
(1,729
|
)
|
|
1,891
|
|
||
|
Operating Earnings
|
$
|
13,991
|
|
|
$
|
11,963
|
|
|
Basic and diluted Operating Earnings per share of common stock
|
$
|
0.37
|
|
|
$
|
0.39
|
|
|
Basic weighted average shares of common stock outstanding
|
37,122,842
|
|
|
30,105,939
|
|
||
|
Diluted weighted average shares of common stock outstanding
|
37,341,050
|
|
|
30,480,689
|
|
||
|
•
|
attempting to structure its financing agreements to have a range of different maturities, terms, amortizations and interest rate adjustment periods;
|
|
•
|
using hedging instruments, interest rate swaps and interest rate caps; and
|
|
•
|
to the extent available, using securitization financing to better match the maturity of the Company’s financing with the duration of its assets.
|
|
Exhibit No.
|
|
Description
|
|
|
|
|
|
3.1
|
|
Articles of Amendment and Restatement of Apollo Commercial Real Estate Finance, Inc., incorporated by reference to Exhibit 3.1 of the Registrant’s Form S-11, as amended (Registration No. 333-160533).
|
|
|
|
|
|
3.2
|
|
Articles Supplementary designating Apollo Commercial Real Estate Finance, Inc.’s 8.625% Series A Cumulative Redeemable Perpetual Preferred Stock, liquidation preference $25.00 per share, par value $0.01 per share, incorporated by reference to Exhibit 3.3 of the Registrant’s Form 8-A filed on July 30, 2012 (File No.: 001-34452).
|
|
|
|
|
|
3.3
|
|
By-laws of Apollo Commercial Real Estate Finance, Inc., incorporated by reference to Exhibit 3.2 of the Registrant’s Form S-11, as amended (Registration No. 333-160533).
|
|
|
|
|
|
4.1
|
|
Specimen Stock Certificate of Apollo Commercial Real Estate Finance, Inc., incorporated by reference to Exhibit 4.1 of the Registrant’s Form S-11, as amended (Registration No. 333-160533).
|
|
|
|
|
|
4.2
|
|
Form of stock certificate evidencing the 8.625% Series A Cumulative Redeemable Perpetual Preferred Stock, liquidation reference $25.00 per share, par value $0.01 per share, incorporated by reference to Exhibit 4.1 of the Registrant’s Form 8-A filed on July 30, 2012 (File No.: 001-34452).
|
|
|
|
|
|
4.3
|
|
Indenture, dated as of March 17, 2014, between the Company and Wells Fargo Bank, National Association, as Trustee, incorporated by reference to Exhibit 4.1 of the Registrant’s Form 8-K filed on March 21, 2014.
|
|
|
|
|
|
4.4
|
|
First Supplemental Indenture, dated as of March 17, 2014, between the Company and Wells Fargo Bank, National Association, as Trustee (including the form of 5.50% Convertible Senior Note due 2019), incorporated by reference to Exhibit 4.2 of the Registrant’s Form 8-K filed on March 21, 2014.
|
|
|
|
|
|
31.1*
|
|
Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
31.2*
|
|
Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
32.1*
|
|
Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of 18 U.S.C. Section 1350 as adopted pursuant to the Sarbanes-Oxley Act of 2002.
|
|
101.INS *
|
|
XBRL Instance Document
|
|
|
|
|
|
101.SCH*
|
|
XBRL Taxonomy Extension Schema
|
|
|
|
|
|
101.CAL*
|
|
XBRL Taxonomy Extension Calculation Linkbase
|
|
|
|
|
|
101.DEF*
|
|
XBRL Taxonomy Extension Definition Linkbase
|
|
|
|
|
|
101.LAB*
|
|
XBRL Taxonomy Extension Label Linkbase
|
|
|
|
|
|
101.PRE*
|
|
XBRL Taxonomy Extension Presentation Linkbase
|
|
*
|
Filed herewith
.
|
|
|
|
|
APOLLO COMMERCIAL REAL ESTATE FINANCE, INC.
|
|
|
|
|
|
|
April 29, 2014
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Stuart A. Rothstein
|
|
|
|
|
Stuart A. Rothstein
|
|
|
|
|
President and Chief Executive Officer
|
|
|
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
By:
|
|
/s/ Megan B. Gaul
|
|
|
|
|
Megan B. Gaul
|
|
|
|
|
Chief Financial Officer, Treasurer and Secretary
|
|
|
|
|
(Principal Financial Officer and Principal Accounting Officer)
|
|
Exhibit
No.
|
|
Description
|
|
|
|
|
|
3.1
|
|
Articles of Amendment and Restatement of Apollo Commercial Real Estate Finance, Inc., incorporated by reference to Exhibit 3.1 of the Registrant’s Form S-11, as amended (Registration No. 333-160533).
|
|
|
|
|
|
3.2
|
|
Articles Supplementary designating Apollo Commercial Real Estate Finance, Inc.’s 8.625% Series A Cumulative Redeemable Perpetual Preferred Stock, liquidation preference $25.00 per share, par value $0.01 per share, incorporated by reference to Exhibit 3.3 of the Registrant’s Form 8-A filed on July 30, 2012 (File No.: 001-34452).
|
|
|
|
|
|
3.3
|
|
By-laws of Apollo Commercial Real Estate Finance, Inc., incorporated by reference to Exhibit 3.2 of the Registrant’s Form S-11, as amended (Registration No. 333-160533).
|
|
|
|
|
|
4.1
|
|
Specimen Stock Certificate of Apollo Commercial Real Estate Finance, Inc., incorporated by reference to Exhibit 4.1 of the Registrant’s Form S-11, as amended (Registration No. 333-160533).
|
|
|
|
|
|
4.2
|
|
Form of stock certificate evidencing the 8.625% Series A Cumulative Redeemable Perpetual Preferred Stock, liquidation reference $25.00 per share, par value $0.01 per share, incorporated by reference to Exhibit 4.1 of the Registrant’s Form 8-A filed on July 30, 2012 (File No.: 001-34452).
|
|
|
|
|
|
4.3
|
|
Indenture, dated as of March 17, 2014, between the Company and Wells Fargo Bank, National Association, as Trustee, incorporated by reference to Exhibit 4.1 of the Registrant’s Form 8-K filed on March 21, 2014.
|
|
|
|
|
|
4.4
|
|
First Supplemental Indenture, dated as of March 17, 2014, between the Company and Wells Fargo Bank, National Association, as Trustee (including the form of 5.50% Convertible Senior Note due 2019), incorporated by reference to Exhibit 4.2 of the Registrant’s Form 8-K filed on March 21, 2014.
|
|
|
|
|
|
31.1*
|
|
Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
31.2*
|
|
Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
32.1*
|
|
Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of 18 U.S.C. Section 1350 as adopted pursuant to the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
101.INS*
|
|
XBRL Instance Document
|
|
|
|
|
|
101.SCH*
|
|
XBRL Taxonomy Extension Schema
|
|
|
|
|
|
101.CAL*
|
|
XBRL Taxonomy Extension Calculation Linkbase
|
|
|
|
|
|
101.DEF*
|
|
XBRL Taxonomy Extension Definition Linkbase
|
|
|
|
|
|
101.LAB*
|
|
XBRL Taxonomy Extension Label Linkbase
|
|
|
|
|
|
101.PRE*
|
|
XBRL Taxonomy Extension Presentation Linkbase
|
|
*
|
Filed herewith.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|